Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.46% |
| 2 | Technology | 18.58% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Financials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRIN
3226
DELISTED
Marin Software
MRIN
| $289K | ﹤0.01% |
37,617
+329
| +0.9% | +$3.49K |
|
|
NEUE
3227
DELISTED
NeueHealth
NEUE
| $289K | ﹤0.01% |
3,443
-6,804
| -66% | -$903K |
|
|
AFMD
3228
DELISTED
Affimed
AFMD
| $287K | ﹤0.01% |
13,948
-15,249
| -52% | -$424K |
|
3229
Amneal Pharmaceuticals
AMRX
$6.16B
| $287K | ﹤0.01% |
141,900
-30,500
| -18% | -$85.5K |
|
|
IGMS
3230
DELISTED
IGM Biosciences
IGMS
| $287K | ﹤0.01% |
12,600
-22,800
| -64% | -$460K |
|
3231
One Stop Systems
OSS
$327M
| $286K | ﹤0.01% |
89,372
-42,685
| -32% | -$162K |
|
|
STRM
3232
DELISTED
Streamline Health Solutions
STRM
| $286K | ﹤0.01% |
16,018
-793
| -5% | -$17.8K |
|
|
TRVG
3233
trivago
TRVG
$354M
| $286K | ﹤0.01% |
49,233
+5,453
| +12% | +$40.9K |
|
|
BLFY
3234
DELISTED
Blue Foundry Bancorp
BLFY
| $285K | ﹤0.01% |
25,600
-1,300
| -5% | -$15.2K |
|
3235
Bristow Group
VTOL
$1.38B
| $284K | ﹤0.01% |
12,100
-1,200
| -9% | -$31.3K |
|
3236
Bank First Corp
BFC
$1.75B
| $283K | ﹤0.01% |
3,700
-400
| -10% | -$31.2K |
|
3237
FreightCar America
RAIL
$241M
| $283K | ﹤0.01% |
75,835
+33,005
| +77% | +$138K |
|
|
FLNT
3238
Fluent
FLNT
$133M
| $282K | ﹤0.01% |
34,833
-1,967
| -5% | -$16.7K |
|
|
SYRS
3239
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $282K | ﹤0.01% |
43,735
+834
| +2% | +$6.78K |
|
3240
Anixa Biosciences
ANIX
$108M
| $281K | ﹤0.01% |
57,200
-28,682
| -33% | -$116K |
|
3241
OptimumBank Holdings
OPHC
$117M
| $281K | ﹤0.01% |
69,000
-8,963
| -11% | -$35.9K |
|
3242
PTC Therapeutics
PTCT
$5.94B
| $281K | ﹤0.01% |
+5,600
| New | +$274K |
|
|
MTCR
3243
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $281K | ﹤0.01% |
579,536
-9,304
| -2% | -$4.58K |
|
3244
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
| $280K | ﹤0.01% |
7,000
-10,600
| -60% | -$469K |
|
3245
Coherent
COHR
$63.2B
| $279K | ﹤0.01% |
+8,000
| New | +$383K |
|
3246
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
| $279K | ﹤0.01% |
2,900
| – | – |
|
3247
Amerant Bancorp
AMTB
$1.14B
| $277K | ﹤0.01% |
11,135
-28,570
| -72% | -$778K |
|
3248
Fidelity High Dividend ETF
FDVV
$10.5B
| $277K | ﹤0.01% |
+8,400
| New | +$312K |
|
|
POL
3249
DELISTED
Polished.com Inc.
POL
| $277K | ﹤0.01% |
10,643
-21,506
| -67% | -$1.04M |
|
3250
KLX Energy Services
KLXE
$35.7M
| $276K | ﹤0.01% |
33,500
+11,400
| +52% | +$68.4K |
|
Similar funds
Jim Simons's Q3 2022 Portfolio in Review
As of Q3 2022, Jim Simons held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Alphabet (Google) Class A worth $498M.
- Jim Simons's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Jim Simons added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Jim Simons's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Jim Simons fully exited Shopify in Q3 2022, selling an estimated $439M.
- Jim Simons's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Jim Simons opened 441 new positions and closed 637 in Q3 2022.
- Jim Simons's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.